BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23101949)

  • 1. Improvement in sensory function via granulocyte-macrophage colony-stimulating factor in rat spinal cord injury models.
    Kim JY; Oh CH; Huang X; Kim MH; Yoon SH; Kim KH; Park H; Park HC; Park SR; Choi BH
    J Neurosurg Spine; 2013 Jan; 18(1):69-75. PubMed ID: 23101949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on glial scar formation after spinal cord injury in rats.
    Chung J; Kim MH; Yoon YJ; Kim KH; Park SR; Choi BH
    J Neurosurg Spine; 2014 Dec; 21(6):966-73. PubMed ID: 25279652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthes Award for Resident Research on Spinal Cord and Spinal Column Injury: granulocyte macrophage colony stimulating factor (GM-CSF) prevents apoptosis and improves functional outcome in experimental spinal cord contusion injury.
    Ha Y; Park HS; Park CW; Yoon SH; Park SR; Hyun DK; Kim EY; Park HC
    Clin Neurosurg; 2005; 52():341-7. PubMed ID: 16626091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of granulocyte-macrophage colony-stimulating factor in preventing apoptosis and improving functional outcome in experimental spinal cord contusion injury.
    Ha Y; Kim YS; Cho JM; Yoon SH; Park SR; Yoon DH; Kim EY; Park HC
    J Neurosurg Spine; 2005 Jan; 2(1):55-61. PubMed ID: 15658127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed granulocyte colony-stimulating factor treatment promotes functional recovery in rats with severe contusive spinal cord injury.
    Lee JS; Yang CC; Kuo YM; Sze CI; Hsu JY; Huang YH; Tzeng SF; Tsai CL; Chen HH; Jou IM
    Spine (Phila Pa 1976); 2012 Jan; 37(1):10-7. PubMed ID: 22024901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of granulocyte colony-stimulating factor and relationship to promotion of angiogenesis after spinal cord injury in rats: laboratory investigation.
    Kawabe J; Koda M; Hashimoto M; Fujiyoshi T; Furuya T; Endo T; Okawa A; Yamazaki M
    J Neurosurg Spine; 2011 Oct; 15(4):414-21. PubMed ID: 21721873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM-CSF inhibits glial scar formation and shows long-term protective effect after spinal cord injury.
    Huang X; Kim JM; Kong TH; Park SR; Ha Y; Kim MH; Park H; Yoon SH; Park HC; Park JO; Min BH; Choi BH
    J Neurol Sci; 2009 Feb; 277(1-2):87-97. PubMed ID: 19033079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM-CSF inhibits apoptosis of neural cells via regulating the expression of apoptosis-related proteins.
    Huang X; Choi JK; Park SR; Ha Y; Park H; Yoon SH; Park HC; Park JO; Choi BH
    Neurosci Res; 2007 May; 58(1):50-7. PubMed ID: 17331604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute granulocyte macrophage-colony stimulating factor treatment modulates neuroinflammatory processes and promotes tactile recovery after spinal cord injury.
    Thomaty S; Pezard L; Xerri C; Brezun JM
    Neuroscience; 2017 May; 349():144-164. PubMed ID: 28274846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of bone marrow stromal cell transplantation with mobilization by granulocyte-colony stimulating factor promotes functional recovery after spinal cord transection.
    Luo J; Zhang HT; Jiang XD; Xue S; Ke YQ
    Acta Neurochir (Wien); 2009 Nov; 151(11):1483-92. PubMed ID: 19499175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in programmed cell death and improvement in functional outcome of transient focal cerebral ischemia after administration of granulocyte-macrophage colony-stimulating factor in rats. Laboratory investigation.
    Kong T; Choi JK; Park H; Choi BH; Snyder BJ; Bukhari S; Kim NK; Huang X; Park SR; Park HC; Ha Y
    J Neurosurg; 2009 Jul; 111(1):155-63. PubMed ID: 19361262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter prospective nonrandomized controlled clinical trial to prove neurotherapeutic effects of granulocyte colony-stimulating factor for acute spinal cord injury: analyses of follow-up cases after at least 1 year.
    Inada T; Takahashi H; Yamazaki M; Okawa A; Sakuma T; Kato K; Hashimoto M; Hayashi K; Furuya T; Fujiyoshi T; Kawabe J; Mannoji C; Miyashita T; Kadota R; Someya Y; Ikeda O; Hashimoto M; Suda K; Kajino T; Ueda H; Ito Y; Ueta T; Hanaoka H; Takahashi K; Koda M
    Spine (Phila Pa 1976); 2014 Feb; 39(3):213-9. PubMed ID: 24299727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hematopoietic factor granulocyte-colony stimulating factor improves outcome in experimental spinal cord injury.
    Pitzer C; Klussmann S; Krüger C; Letellier E; Plaas C; Dittgen T; Kirsch F; Stieltjes B; Weber D; Laage R; Martin-Villalba A; Schneider A
    J Neurochem; 2010 May; 113(4):930-42. PubMed ID: 20202082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor attenuates spinal cord injury-induced mechanical allodynia in adult rats.
    Kato K; Koda M; Takahashi H; Sakuma T; Inada T; Kamiya K; Ota M; Maki S; Okawa A; Takahashi K; Yamazaki M; Aramomi M; Hashimoto M; Ikeda O; Mannoji C; Furuya T
    J Neurol Sci; 2015 Aug; 355(1-2):79-83. PubMed ID: 26055312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of dendritic-like cells and neural stem/progenitor cells in injured spinal cord by GM-CSF.
    Hayashi K; Ohta S; Kawakami Y; Toda M
    Neurosci Res; 2009 May; 64(1):96-103. PubMed ID: 19428687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial.
    Derakhshanrad N; Saberi H; Yekaninejad MS; Joghataei MT; Sheikhrezaei A
    J Neurosurg Spine; 2018 Jul; 29(1):97-107. PubMed ID: 29701561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats.
    Renno WM; Al-Khaledi G; Mousa A; Karam SM; Abul H; Asfar S
    Neuropharmacology; 2014 Feb; 77():100-19. PubMed ID: 24071567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective Effects of Direct Intrathecal Administration of Granulocyte Colony-Stimulating Factor in Rats with Spinal Cord Injury.
    Chen WF; Chen CH; Chen NF; Sung CS; Wen ZH
    CNS Neurosci Ther; 2015 Sep; 21(9):698-707. PubMed ID: 26190345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-specific GM-CSF-overexpressing neural stem cells improve graft survival and functional recovery in spinal cord injury.
    Kim HJ; Oh JS; An SS; Pennant WA; Gwak SJ; Kim AN; Han PK; Yoon DH; Kim KN; Ha Y
    Gene Ther; 2012 May; 19(5):513-21. PubMed ID: 22011644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor.
    Park HC; Shim YS; Ha Y; Yoon SH; Park SR; Choi BH; Park HS
    Tissue Eng; 2005; 11(5-6):913-22. PubMed ID: 15998231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.